Johnson & Johnson JOHNSON & JOHNSON ORD (CDI)
Johnson & Johnson JOHNSON & JOHNS.../ US4781601046 /
0R34
15/11/2024 20:12:45
|
Diferencia
+1.4700
|
Volumen |
Bid15/11/2024 |
Ask15/11/2024 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
154.1800USD
|
+0.96%
|
14,588 Volumen de negocios: 2.23 millones |
-Volumen de oferta: - |
-Tamaño/ Volumen/ Formato de Ask: - |
370.77 mil millonesUSD |
3.05% |
11.10 |
Descripción de negocio
Johnson & Johnson and its subsidiaries (the "Company") have employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson is a holding company, which has more than 250 operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887.
Consejo de gestión & Consejo de supervisión
CEO |
Joaquin Duato |
Consejo de gestión |
Joseph Wolk, Dr. Peter M. Fasolo, Dr. William N. Hait, James Swanson, Jennifer Taubert, Kathryn E. Wengel, Vanessa Broadhurst, John C. Reed, M.D., Ph.D., Liz Forminard, Tim Schmid |
Consejo de supervisión |
Joaquin Duato, A. Eugene Washington, M.D., Anne M. Mulcahy, D. Scott Davis, Darius Adamczyk, Dr. Jennifer A. Doudna, Dr. Mary Beckerle, Dr. Nadja West, Hubert Joly, Marillyn A. Hewson, Mark A. Weinberger, Mark B. McClellan, Paula A. Johnson, M.D. |
Datos de la empresa
Nombre: |
Johnson & Johnson |
Dirección: |
One Johnson & Johnson Plaza,,New Brunswick, New Jersey 08933, USA |
Teléfono: |
+1-732-524-0400 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.jnj.com |
Industria: |
Healthcare |
Sector: |
Pharmaceutical Industry |
Subsector: |
Pharmaceuticals |
Fin del año financiero: |
31/12 |
Acciones de libre circulación: |
77.97% |
Fecha de OPI: |
24/09/1944 |
Calendario de la empresa
CW 48 | 26/11/2024
Record Date
|
CW 48 | 26/11/2024
Ex-Dividend
|
CW 50 | 10/12/2024
Dividend Payment
|